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Automated sequence analysis of a 410-bp region of the oxyR gene in 105 Mycobacterium tuberculosis complex
isolates identified a polymorphic nucleotide that differentiatedMycobacterium bovis isolates from other complex
members. All 29 M. bovis isolates sequenced had an adenine residue at nucleotide 285, whereas all 76 other
complex isolates had a guanine residue. PCR-restriction fragment length polymorphism analysis of oxyR with
restriction endonuclease AluI in an additional 255 complex isolates from widespread intercontinental sources
confirmed and extended the unique association of adenine at position 285 with M. bovis isolates.
The four members of the Mycobacterium tuberculosis com-
plex (M. tuberculosis, M. bovis, M. microti, and M. africanum)
share 85 to 100% DNA-DNA relatedness (9). Differentiation
among the members is currently based mainly on analysis of
phenotypic characteristics such as colony morphology, growth
rate, and biochemical tests (7, 14). In part because of their
close genetic relatedness and slow growth, species assignment
is time-consuming and difficult.
Several phenotypic and genotypic strategies have been used
in an attempt to differentiate among members of the M. tuber-
culosis complex. Although characterization of mycolic acid
profiles by high-performance liquid chromatography has some-
times been useful for the differentiation of M. bovis BCG
isolates fromM. bovis non-BCG isolates and other members of
the complex (4), this technique requires substantial bacterial
growth, can be labor intensive, and is not widely available. In
addition, the technique does not distinguish among the four
species of the M. tuberculosis complex. Several nucleic acid-
based strategies such as restriction fragment length polymor-
phism (RFLP) analysis or sequencing of target genes (5, 10, 16,
18) or commercially available test systems (Accuprobe; Gen-
Probe, San Diego, Calif.) are unable to unambiguously differ-
entiate among M. tuberculosis complex species. More recently,
differentiation among the members of M. tuberculosis complex
has been attempted by using random amplified polymorphic
DNA analysis (17) and amplification ofM. tuberculosis-specific
sequences (20). Although some success has been achieved in
distinguishing M. tuberculosis (strict sense) (20) and M. bovis
(17) from other M. tuberculosis complex organisms, relatively
few samples have been analyzed. Inasmuch as it is sometimes
important for public health reasons to distinguish M. bovis
isolates from otherM. tuberculosis complex species, a rapid and
unambiguous differentiation strategy would be useful.
In Escherichia coli and Salmonella typhimurium, oxyR func-
tions as a sensor and a transcriptional regulator of proteins
involved in the oxidative stress response (3). The homolog of
the oxyR gene in M. tuberculosis complex organisms contains
numerous deletions and frameshift mutations (2, 19). Because
oxyR in M. tuberculosis isolates probably does not encode a
functional protein (2, 19), it is referred to as a pseudogene.
Inasmuch as pseudogenes accumulate mutations at an in-
creased rate compared with functional genes (12, 13), we
thought it possible that oxyR might contain polymorphic nu-
cleotide sites useful for differentiating among the closely re-
lated members of the M. tuberculosis complex (11). In this
report we describe a polymorphic nucleotide located at posi-
tion 285 of the oxyR gene that differentiates M. bovis from
other complex members.
Bacterial strains. Three hundred sixty isolates of the M.
tuberculosis complex were analyzed, including samples of M.
microti (n 5 9 isolates), M. africanum (n 5 11), M. bovis (n 5
124), and M. tuberculosis strict sense (n 5 214). Two M. bovis
BCG strains were also studied. The M. bovis isolates were
recovered in California (n 5 23 isolates), Colorado (n 5 2),
Hawaii (n 5 1), Kansas (n 5 1), Maryland (n 5 2), Montana
(n 5 5), New Mexico (n 5 2), New York (n 5 3), Texas (n 5
24), Virginia (n 5 1), Canada (n 5 22), Mexico (n 5 13), The
Netherlands (n 5 5), Switzerland (n 5 6), and unknown local-
ities (n5 14). These organisms were cultured from a variety of
hosts, including humans (n 5 47 isolates), bison (n 5 6), cattle
(n 5 52), cougars (n 5 2), domestic cats (n 5 2), seals (n 5 2),
elk (n 5 7), and deer (n 5 6). The M. bovis sample included
organisms with a range of IS6110 copy numbers (0 to 19 cop-
ies) and patterns. The M. microti specimens were recovered
from voles (n 5 7), a pig (n 5 1) in The Netherlands, and a
rock hyrax (n 5 1) in South Africa. The M. africanum isolates
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were recovered from humans with tuberculosis in Sierra Le-
one.
The 214 M. tuberculosis strains were obtained from wide-
spread global localities including Brazil (n 5 9 isolates), Chile
(n 5 14), Ecuador (n 5 1), Mexico (n 5 14), Venezuela (n 5
8), Trinidad-Tobago (n 5 2), India (n 5 1), Japan (n 5 3),
Mongolia (n 5 3), Nepal (n 5 1), Philippines (n 5 6), South
Korea (n 5 3), Thailand (n 5 4), Tibet (n 5 1), Vietnam (n 5
3), Germany (n 5 1), Italy (n 5 1), The Netherlands (n 5 5),
Portugal (n5 1), Romania (n5 9), Spain (n5 3), Switzerland
(n 5 4), former Yugoslavia (n 5 2), Israel (n 5 10), Turkey
(n 5 2), Algeria (n 5 1), Guinea (n 5 2), Kenya (n 5 20),
Somalia (n 5 1), Yemen (n 5 4), Zaire (n 5 1), and different
regions of the United States including California (n 5 4 iso-
lates), Colorado (n 5 3), New York City (n 5 20), and Texas
(n 5 47). This collection of M. tuberculosis isolates represents
the range of IS6110 fingerprints diversity recently described in
the species (8, 20a) and includes organisms recovered from
patients with pulmonary and extrapulmonary tuberculosis. The
organisms in the sample had from 0 to 21 copies of IS6110
(22). In addition, the isolates include members of three genetic
categories into which all M. tuberculosis isolates can be as-
signed on the basis of sequence polymorphisms located in katG
and gyrA (21). Moreover, organisms classified into several
groups on the basis of a multiplex PCR analysis (15) were
included in the analysis.
Species assignment of isolates of M. tuberculosis strict sense,
M. bovis, and M. microti were made on the basis of analysis of
accepted phenotypic criteria (7, 14). Some of the M. bovis
isolates recovered from humans have been described previ-
ously (1). No simple set of phenotypic features that can be used
to differentiate M. africanum from other M. tuberculosis com-
plex members is generally accepted. The organisms that we
studied were identified as M. africanum on the basis of the
results of an extensive panel of phenotypic criteria used at the
Armauer-Hansen-Institut, Wurzburg, Germany. In addition to
other criteria used for classification, these organisms did not
grow in the presence of 1 mg of thioxyphene-2-carboxylic acid
hydrazide per ml and were susceptible to pyrazinamide (24).
Automated DNA sequencing of the oxyR locus. The DNA
sequence of a 410-bp region of oxyR was analyzed in 105
organisms, including M. tuberculosis (n 5 60 isolates), M. bovis
(n 5 29), M. microti (n 5 9), and M. africanum (n 5 7). A
548-bp segment of oxyR was amplified with the following oli-
gonucleotide primers: forward primer, 59-GGTGATATATCA
CACCATA-39; reverse primer, 59-CTATGCGATCAGGCGT
ACTTG-39. A GeneAmp System 9600 thermocycler (Perkin-
Elmer Corp, Foster City, Calif.) was used with the following
parameters: annealing temperature of 558C for 21 s, extension
at 728C for 22 s, and a denaturation step at 948C for 21 s. Each
reaction was preceded by an initial denaturation step at 948C
for 60 s and was terminated with a final extension step at 728C
for 5 min. DNA sequencing reactions were performed with the
Taq DyeDeoxy terminator cycle sequencing kit (Applied Bio-
systems, Inc., Foster City, Calif.), and data were generated with
an ABI 373A automated instrument. The sequence data were
assembled and edited electronically with the EDITSEQ,
ALIGN, and MEGALIGN programs (DNASTAR, Madison,
Wis.) and were compared with a published sequence (19) for
oxyR (GenBank accession number U18263).
The oxyR analysis showed that all 29M. bovis isolates had an
adenine at position 285. In striking contrast, all 76 other M.
tuberculosis complex (M. tuberculosis, M. africanum, and M.
microti) strains sequenced had a guanine at position 285 (Fig.
1A). With the exception of an occasional rare nucleotide sub-
stitution, no additional sequence variation was found in the
410-bp region studied.
PCR-RFLP analysis of allelic variation at oxyR nucleotide
position 285. Inasmuch as the sequence data showed that all
M. bovis isolates had an adenine, whereas otherM. tuberculosis
complex isolates had a guanine, at position 285 of oxyR, a
PCR-RFLP strategy was designed to simplify the differentia-
tion of allelic variation at this polymorphic site. A 548-bp
fragment of oxyR containing nucleotide 285 was amplified by
PCR as described above. The PCR product (10 ml) was di-
gested with 4 U of AluI (New England Biolabs, Beverly,
Mass.), a restriction enzyme that cleaves at an AGCT se-
quence. The oxyR gene of M. bovis has an AGCT sequence
beginning at the adenine residue located at nucleotide 285.
Digestion was carried out at 378C for 90 min, and the resulting
DNA fragments were electrophoretically separated with a
1.8% agarose gel containing 0.03% ethidium bromide at a
constant voltage of 90 V for approximately 2 h. Digested and
undigested samples from each strain were electrophoresed in
adjacent lanes. The DNA bands were visualized with a UV
transilluminator and were documented by photography. There
are three AluI restriction sites in the 548-bp sequence of oxyR
in M. tuberculosis complex organisms with a guanine at nucle-
otide 285. Digestion with AluI should yield four DNA frag-
ments of 236, 227, 55, and 30 bp. However, the electrophoretic
conditions used in the present study were formulated to iden-
tify only one band at about 230 bp for DNA samples from M.
tuberculosis complex organisms. This band represents both the
FIG. 1. Identification of polymorphism at oxyR nucleotide 285. (A) DNA
sequencing chromatogram of the region with a polymorphism located at nucle-
otide 285 in oxyR. The numbers noted on top of the peak tracings and below the
nucleotides in the chromatograms are arbitrary marker positions and have no
relevance to the actual nucleotide positions of oxyR. TheM. bovis isolates studied
had an adenine at nucleotide 285, whereas all other M. tuberculosis complex
isolates studied had a guanine. (B) Results of a PCR-RFLP strategy to detect
variation at oxyR nucleotide 285. A 548-bp segment of oxyR was amplified by
PCR and was digested with AluI. Even-numbered lanes contain the amplified
gene segment, and odd-numbered lanes have the same samples treated with
AluI. Lanes 1 and 3, digested DNAs from a representative M. bovis isolate and
M. bovis BCG (Brazil), respectively. Lanes 5, 7, 9, 11, and 13, digested DNAs
from H37Ra, H37Rv, a clinical isolate of M. tuberculosis, M. microti, and M.
africanum, respectively.










236-bp and the 227-bp oxyR DNA fragments. The M. bovis
isolates (with an adenine at nucleotide 285) have four restric-
tion sites for AluI in the amplified oxyR gene segment, and
therefore, five DNA fragments (236, 148, 79, 55, and 30 bp)
should be produced. However, the electrophoretic conditions
used identified a three-band pattern of 236, 148, and 79 bp for
all M. bovis isolates (Fig. 1B).
A total of 255 M. tuberculosis complex strains were analyzed
by this method, including 95 isolates ofM. bovis, 2 strains ofM.
bovis BCG, 154 isolates of M. tuberculosis, and 2 isolates each
ofM. africanum andM. microti. AllM. bovis isolates, including
the two M. bovis BCG strains, had the expected three-band
pattern (Fig. 1B). In contrast, all otherM. tuberculosis complex
isolates had the expected one-band pattern.
In preliminary studies, isolates in five early BACTEC (Bec-
ton-Dickinson, Sparks, Md.) cultures with growth indices of
between 50 and 120 were also analyzed for the PCR-RFLP
pattern of oxyR. DNA was extracted from these cultures, and
isolates were assigned to the M. tuberculosis complex by hsp65
sequence analysis as described previously (10). The isolates in
all BACTEC cultures studied yielded the one-band pattern.
Our analysis of polymorphic nucleotide 285 in the oxyR
genes of 360 M. tuberculosis complex organisms from wide-
spread geographic sources and host species was 100% sensitive
and specific for distinguishing M. bovis isolates from other
complex members. The data indicate that use of either direct
sequence analysis or a PCR-RFLP strategy to identify poly-
morphism at nucleotide 285 in oxyR reliably differentiates M.
bovis from otherM. tuberculosis complex members. Analysis of
oxyR nucleotide 285 variation does not differentiate M. bovis
BCG isolates from M. bovis non-BCG isolates. Although our
data show 100% specificity of the nucleotide at position 285 for
M. bovis among the 360 strains studied, it is possible that
analysis of larger numbers of samples will identify organisms
for which this association breaks down. No reasonable amount
of strain sampling can permit us to rule out this possibility.
However, it is clear that these organisms will be relatively rare
or confined to restricted geographic localities or host species.
Epidemiologic investigations (6, 23) and clinical decisions
are sometimes based on phenotypic classification of M. tuber-
culosis complex organisms. Molecular strategies for assignment
of M. tuberculosis complex organisms to a particular species
have largely been unsuccessful because of their lack of resolu-
tion and requirement for sophisticated and expensive equip-
ment (4, 10, 18). Other M. bovis-specific (17) and M. tubercu-
losis (strict sense)-specific (20) methods have been described,
but they have not been applied to analyses of large samples of
isolates from diverse geographic localities. The PCR-RFLP
method used to identify the M. bovis-specific oxyR nucleotide
285 is inexpensive, rapid, highly sensitive, and specific. Prelim-
inary results indicate that the methodology is also applicable to
DNA extracted from early BACTEC culture specimens. Al-
though our study did not analyze other specimen types, it is
possible that this method could also be successfully applied to
some primary clinical specimens, but additional studies are
required to address this issue. Analysis of oxyR nucleotide 285
polymorphism could also be used to obtain precise measures of
prevalence and incidence rates for human infections caused by
M. bovis isolates. The strategy would be especially useful in
areas of Africa, South and Central America, Southeast Asia,
and other regions where the transmission of M. bovis from
animals to humans and vice versa can occur or is a suspected
problem. The ability of this method to distinguish M. bovis
BCG strains fromM. tuberculosis (strict sense) isolates will also
be useful in the characterization of slowly growing mycobacte-
ria recovered from patients treated with M. bovis BCG for
bladder cancer or some BCG-immunized immunocompro-
mised patients with tuberculosis.
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